Skip to main content

Table 1 Clinical characteristics of 86 patients with newly diagnosed AML and expression of miR-96

From: Prognostic value of miR-96 in patients with acute myeloid leukemia

Characteristics Cases miRc96 expression level x 2 p
Low expression High expression
Sex Male 42 28 14 0.374 0.541
  Female 44 32 12   
Age <60 64 46 18 0.527 0.468
  ≥60 22 14 8   
WBC <10 26 11 15 13.323 0.000*
  ≥10 60 49 11   
HGB <80 54 42 12 4.415 0.036*
  ≥80 32 18 14   
PLT <50 48 38 10 4.550 0.033*
  ≥50 38 22 16   
Blast in BM <50% 37 21 16 5.212 0.022*
  ≥50% 49 39 10   
FAB subtype M1/M2 35 25 10 0.791 0.673
  M4/M5 47 33 14   
  Other 4 2 2   
Cytogenitics Favorable 12 7 5 0.516 0.776
  Intermediate 39 26 13   
  Unfavorable 14 10 4   
Complete Remission Y 42 28 14 1.551 0.213
  N 30 24 6   
  1. *P<0.05.